The TVM Healthcare Afiyah Fund LP, which is the company’s second Middle Eastern capital pool, closed today at a cost of roughly $250 million. TVM Capital Healthcare is an international healthcare expansion and growth capital investor.
Since 2009, TVM Capital Healthcare has operated in the Middle East, and since 2021, it has expanded to Southeast Asia. By offering extremely attractive returns and showcasing the firm’s ability to originate deals and develop successful, sustainable companies with excellent growth prospects and strong management teams, the new fund builds on the firm’s prior success investing in the region.
TVM Capital Healthcare finds unmet healthcare needs and makes investments in start-up businesses that improve local communities for the better while providing investors with substantial returns. The company has established a strong reputation for being the first foreign fund manager to invest in and run significant healthcare businesses in the Kingdom. Additionally, in order to facilitate these companies’ plans to expand into Saudi Arabia and the larger GCC, it invests in healthcare growth deals in Europe and the United States. TVM Capital Healthcare maximizes its contribution to the transformation of the Saudi economy and enhances access to world-class products, technologies, and services in the region with this two-pronged, highly catalytic approach.
DEBx Medical, neurocare Group, and Baraya Extended Care are a few of the fund’s initial investments.
Genes and longevity, oncology, pharmaceutical manufacturing, and diagnostics are among the other deals.
Bandr Alhomaly, Managing Director and CEO of Jada Fund of Funds said, “The closing of the TVM Healthcare Afiyah Fund marks an important milestone in mobilizing private capital into Saudi Arabia’s healthcare sector, and we are pleased to lead the investment, providing capital to support the development of the sector in line with Vision 2030.”
Dr. Helmut M. Schuehsler, Chairman and CEO of TVM Capital Healthcare, added, “We are proud of attracting a distinguished group of institutional and family investment groups from Saudi Arabia, other GCC countries, and Europe for a specialist pool of capital of this size being deployed in domestic companies in the Kingdom and international companies entering the market. We are uniquely positioned for success because our leadership team comprises executives with long-standing expertise in Europe and the U.S. who have built excellent international networks throughout their careers, alongside local Saudi healthcare experts. Plus, we have been investing in the GCC and Egypt for over 13 years, and more specifically, operating in Saudi Arabia since 2015 through our former portfolio companies, ProVita International Medical Center and Cambridge International Medical Center. Today, we are truly excited about our ability to enhance the local and regional healthcare ecosystem at a much larger scale, helping to improve access to high-quality patient care, medical products, and treatment regimens across the Kingdom.”
